Philips launches foetal-maternal monitors in EU, Africa and Middle East:
This article was originally published in Clinica
Philips Medical Systems has launched two new foetal-maternal ultrasound monitors across a number of European, African and Middle Eastern countries. Both the Avalon FM40 antepartum (pre-birth) and FM50 intrapartum (during labour) monitors feature a built-in colour monitor, and an external display with touch-screen capability that can be mounted in a different room to the patient. This allows the doctor to interact with the monitor even when they are away from the patient's bedside. Both monitors can measure maternal blood pressure, SpO2, maternal and foetal ECG and maternal heart rate. The systems can monitor the mother and up to three babies simultaneously. In addition, the transducers on both devices are constructed with a soft material to increase patient comfort, said the firm.
You may also be interested in...
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.
Boehringer expects Jardiance’s new chronic kidney disease indication to keep its sales growing by double-digit percentages over the coming years, aided by the drug’s ability to reduce hospitalizations.